Stonebridge Financial Planning Group, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 41 filers reported holding SECOND SIGHT MED PRODS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Stonebridge Financial Planning Group, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2021$2,000
-33.3%
3750.0%0.00%
-50.0%
Q1 2021$3,000
+200.0%
3750.0%0.00%
+100.0%
Q4 2020$1,0003750.0%0.00%
Q3 2020$0
-100.0%
375
-65.9%
0.00%
-100.0%
Q2 2020$1,0000.0%1,0990.0%0.00%0.0%
Q1 2020$1,0001,0990.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Altium Capital Management LP 373,867$1,847,0000.43%
NewGen Asset Management Ltd 200,000$988,0000.37%
SABBY MANAGEMENT, LLC 174,900$864,0000.12%
Kepos Capital LP 100,000$494,0000.04%
Hudson Bay Capital Management LP 380,404$1,879,0000.02%
Paloma Partners Management Co 139,081$687,0000.01%
Cutler Group LLC / CA 24,495$121,0000.01%
Cutler Group LLC / CA 35,000$36,0000.00%
Stratos Wealth Partners, LTD. 15,543$77,0000.00%
Lake Point Wealth Management 1,000$5,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders